Wuliangye's price inversion — list held, real price fell below dealer cost

On 7 December 2025 Wuliangye handed dealers a 119元 discount per bottle: the official 打款价 of 1019元 was held, but the real open-to-dealer price was cut to 900元 — the first price cut by the flagship 普五 in roughly eleven years. The wholesale price had already fallen to about 850元 a bottle, and some e-commerce subsidy channels pushed it to 640元 online, below the dealers' cost of around 920元.

The result was a price inversion that had been building for about two years: distributors were buying at a price above what they could sell for, so 'selling one bottle loses money on one bottle'. The 2025 accounts show the strain. Wuliangye's revenue for the first three quarters was 609.45亿元, down 10.26%, and net profit fell 13.72% to 215.11亿元. The single quarter of Q3 was the worst since its 1998 listing: revenue down 52.66% and net profit down 65.62%.

Inventory piled up as bills were forced out. Stock turns reached 316.05 days, the worst in four years, and dealers' contract liabilities fell from 116.90亿元 to 92.68亿元, a 21% drop — a sign that advance orders had dried up. The dealer network itself shrank from over 3,700 to 3,587, and the top five customers' share of revenue leapt from 21.12% in H1 2024 to 56.96% in H1 2025 as fewer hands carried more of the burden.

Wuliangye's response was a 'shock therapy' in April 2026: it paused shipments of 普五 to clear the channel, and the wholesale price recovered to roughly 950元. The lesson of the case is that holding a list price while the real price collapses does not protect the brand — it only pushes the loss downward onto the dealers who carry the inventory.